Column Capital Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$6.06K Hold
38
﹤0.01% 580
2023
Q2
$11K Sell
38
-7
-16% -$2.13K ﹤0.01% 517
2023
Q1
$14.4K Hold
45
﹤0.01% 488
2022
Q4
$13.2K Hold
45
﹤0.01% 474
2022
Q3
$10K Hold
45
﹤0.01% 475
2022
Q2
$10K Hold
45
﹤0.01% 483
2022
Q1
$12K Hold
45
﹤0.01% 479
2021
Q4
$12K Hold
45
﹤0.01% 493
2021
Q3
$13K Hold
45
﹤0.01% 440
2021
Q2
$12K Hold
45
﹤0.01% 459
2021
Q1
$12K Hold
45
﹤0.01% 440
2020
Q4
$12K Hold
45
﹤0.01% 440
2020
Q3
$11K Sell
45
-15
-25% -$3.16K ﹤0.01% 432
2020
Q2
$11K Buy
60
+9
+18% +$1.72K ﹤0.01% 465
2020
Q1
$8K Sell
51
-9
-15% -$1.65K ﹤0.01% 426
2019
Q4
$10K Buy
+60
New +$10K 0.01% 450

Other funds holding PODD

Column Capital Advisors's PODD Position: Q3 2023 in Review

Column Capital Advisors held its Insulet (PODD) position steady in Q3 2023 at 38 shares worth $6.06K. The position accounts for ﹤0.01% of the portfolio, ranked #580.

Column Capital Advisors first reported a position in PODD in Q4 2019 and has held it in 16 quarters since. The position peaked at $14.4K in Q1 2023. 528 funds tracked by Wall St. Rank hold PODD as of Q3 2023.

  • Column Capital Advisors held 38 shares of Insulet worth $6.06K as of Q3 2023.
  • Column Capital Advisors left its Insulet share count unchanged in Q3 2023.
  • Insulet made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #580 holding.
  • Column Capital Advisors first reported a position in Insulet in Q4 2019 and has held it in 16 quarters since.
  • Column Capital Advisors's Insulet position peaked at $14.4K in Q1 2023.
  • 528 funds tracked by Wall St. Rank held Insulet as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.